Use of in vitro and in vivo models to test candidate Alzheimer's disease risk genes from GWAS
MS4A4A/MS4A6A expression influences AD associated phenotypes and may be potential therpaeutic targets to lower AD risk.
Authors
- Yaíma L. Lightfoot (ORCID: https://orcid.org/0009-0001-2153-1906)
- Grace B. Peppler
- Michael D.E. Sewell (ORCID: https://orcid.org/0000-0003-0113-6551)
- Alexandra Botté (ORCID: https://orcid.org/0000-0003-4631-8404)
- Jim Ray
- Alison M Goate
- Alexandra Münch
- Edoardo Marcora
Institutions
- Alzheimer’s Disease Neuroimaging Initiative (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70855_098683
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00